🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
This is a single center, "modified standard design" dose escalation study d...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-09
Trial ID
NCT01385423
Treatments Being Tested
This phase II clinical trial studies how well personalized natural killer (...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-05-19
Trial ID
NCT02727803
RATIONALE: Giving an infusion of natural killer cells from a donor after a ...
Status
Completed
Location
University of Ulsan, Asan Medical Center
Start Date
2009-01
Trial ID
NCT00823524
Treatments Being Tested
The goal of this clinical research study is to learn if transferring the do...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-07
Trial ID
NCT00941928
Treatments Being Tested
The main purpose of this study is to find out how well participants with re...
Status
Completed
Location
Rady Children's Hospital and Health Center
Start Date
2003-11
Trial ID
NCT00186875
Treatments Being Tested
ReKORD is an observational study (Registry) enrolling participants who have...
Status
Recruiting
Location
Medizinische Hochschule Hannover
Start Date
2022-06-14
Trial ID
NCT05290662
Treatments Being Tested
Background: Long-term success of organ transplantation is limited by the i...
Status
Recruiting
Location
Service de transplantation, néphrologie et immunologie clinique, Hôpital Edouard Herriot (HCL)
Start Date
2020-12-03
Trial ID
NCT03955172
Treatments Being Tested
This example study evaluates the safety, tolerability, and preliminary anti...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07627711